North East and North Cumbria
ICS Formulary
ICS Formulary
5 Infections
05-02-03 Polyene antifungals
.
unlicensed 
| Amphotericin |
|
Formulary
|
|
 MHRA Drug Safety Update (July 2018): Parenteral amphotericin B: reminder of risk of potentially fatal adverse reaction if formulations confused MHRA Drug Safety Update (July 2020): Liposomal and lipid- complex formulations: name change to reduce medication errors |
|
Links
- COVID-19 Therapeutic Alert
- Interim Clinical Commissioning Policy: Antivirals or neutralising monoclonal antibodies in the treatment of COVID-19 in hospitalised patients (Version 5 - effective from 10th February 2022)
- MHRA Drug Safety Update (July 2018): Parenteral amphotericin B: reminder of risk of potentially fatal adverse reaction if formulations confused
- MHRA Drug Safety Update (July 2020): Liposomal and lipid- complex formulations: name change to reduce medication errors
NENC ICB - Cellulitis Diagnosis and Management in Ambulatory Adults in primary care; Supporting Information- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG63: Antimicrobial stewardship: changing risk-related behaviours in the general population
- North of Tyne, Gateshead and North Cumbria - Antibiotic and Diagnostic quick reference tools
- Primary Care Antimicrobial Guidelines
- TEWV: Antibiotic Prescribing Procedure
- UK Interim Clinical Commissioning Police - Therapies for patients with symptomatic hospital-onset COVID-19